Bluebird bio agrees to be acquired by Carlyle and SK Capital
Feb 21 (Reuters) - Bluebird bio BLUE.O said on Friday it has entered into a agreement to be acquired by funds managed by global investment firms Carlyle CG.O and SK Capital Partners. (Reporting by Sneha S K; Editing by Shinjini Ganguli) ((Sneha.SK@thomsonreuters.com;))
Recent news on bluebird bio
See all newsBrief: Bluebird Bio Announces Completion Of Acquisition By Carlyle And SK Capital
Brief: Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
Brief: Carlyle, SK Capital Partners And Bluebird Bio Provide Updated Tender Instructions
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment